Navigation Links
Replidyne's Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile
Date:9/19/2007

1 ug/mL) for all C. difficile strains tested. In contrast, widely used agents such as vancomycin and metronidazole did not reduce toxin production in these high density cultures even at drug concentrations well above those required to inhibit growth of the bacteria. The levels of toxins were monitored by immunoassays using antibodies that specifically recognize two disease-causing factors, toxin A and toxin B. The dramatic reduction in the deleterious effects of the toxins was directly demonstrated by the gold standard cytotoxicity assay, which uses human fibroblasts to confirm the ability of REP3123 to block toxin production. The FDA has not approved REP3123 for marketing in this or any other indication.

"CDAD is a challenging disease because of the difficulty in managing patients with severe manifestations as well as the problem of recurrence in those patients who recover from the initial episode. As the disease is primarily toxin-mediated, new therapies that act by means other than simply eradicating the bacteria may be very helpful and should be studied," stated Stuart Johnson, M.D., Associate Professor of Medicine, Stritch School of Medicine, Loyola University and the Hines VA Medical Center in Chicago. "The finding that REP3123 has a direct impact on inhibiting toxin production of C. difficile bacteria is very important and equally as exciting."

"C. difficile-associated diseases have become a serious health matter in both the hospital and community settings," stated Kenneth J. Collins, Replidyne President & CEO. "These results, along with the sporulation-inhibition findings also reported today, are very encouraging and we look forward to the further development of REP3123."

About Clostridium difficile

C. difficile is a Gram-positive anaerobic bacterium that causes C. difficile-associated disease (CDAD). CDAD is on the rise worldwide, both in terms of number of cases and severity of the disease. Most cases of CDAD occur in a hospital se
'/>"/>

SOURCE Replidyne, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
3. Late Breaking Data Released at ADA Showed that the Investigational Use of Januvia and Metformin as Initial Combination Therapy Provided Significant Glucose Lowering Efficacy over 54 Weeks in Patients with Type 2 Diabetes
4. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
5. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
6. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
7. Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
10. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
11. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015  New York College of ... class Intellectual Properties portfolio with U.S. Patent #8,996,098 donated ... This patent represents a surgical instrument that allows surgeons ... if it were in the traditional format of a ... against medical databases during surgery, thus providing the surgeon ...
(Date:4/1/2015)... MOUNTAIN VIEW, Calif. , April ... BSX ) announces that it has signed a ... medical device company that develops, manufactures and sells ... transluminal drainage of targeted areas within the gastrointestinal ... week. The Xlumena portfolio includes ...
(Date:4/1/2015)... April 1, 2015  The first national study ... supplements to treat attention-deficit/hyperactivity disorder (ADHD) among children ... of children with ADHD were receiving behavioral therapy ... Control and Prevention (CDC) study, "Treatment of Attention-Deficit/Hyperactivity ... published today in The Journal of Pediatrics ...
Breaking Medicine Technology:Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3Boston Scientific Agrees to Acquire Xlumena 2Boston Scientific Agrees to Acquire Xlumena 3Boston Scientific Agrees to Acquire Xlumena 4Boston Scientific Agrees to Acquire Xlumena 5CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 2CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 3CDC publishes first national study on use of behavioral therapy, medication and dietary supplements for ADHD in children 4
... TRIANGLE PARK, N.C., Oct. 16 Liquidia,Technologies announces ... University of North Carolina-Chapel Hill professor, Joseph DeSimone. ... will discuss drug delivery,applications of the PRINT(TM) platform ... http://www.newscom.com/cgi-bin/prnh/20060614/CLW002LOGO ), -- Prostate ...
... Oct. 15 The following was,released today by ... conference call to discuss a new report from ... America,s Health (TFAH),"Pandemic Influenza: Warning, Children At-Risk." The ... caring for children during a possible,pandemic flu outbreak ...
Cached Medicine Technology:Targeted Nanoparticles Offer Promise in the Battle Against Cancer 2
(Date:4/1/2015)... York, NY (PRWEB) April 01, 2015 This ... partnering with the Oral Cancer Foundation for an Open House ... , from 9 a.m. to 4 p.m. An appointment is ... midtown dental office at 212-689-0024. In addition, Herald ... cancer screenings during the entire month of April at the ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Bird B ... industrial and residential applications now offers a complete line ... wide range of bird netting products quickly, safely and ... the success of any bird netting installation. It’s important ... the planning stages of a project. This includes deciding ...
(Date:4/1/2015)... LINCOLN, R.I. (PRWEB) April 01, 2015 After ... potholes. Driving over these potholes can lead to costly damage, ... your vehicle. , Amica is sharing the following suggestions from ... have plenty of tread and be inflated to the manufacturer’s ... change in vehicle handling, excessive vibration and uneven tire wear ...
(Date:4/1/2015)... April 01, 2015 Taking an important ... National League for Nursing Commission for Nursing Education Accreditation ... approved the first NLN CNEA Board of Commissioners. Working ... ANEF, the 15-member board will provide leadership and direction ... all accreditation decisions for nursing programs that seek accreditation ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 BioPlus ... innovative specialty pharmacies, has released a new app to ... guidelines for treating chronic hepatitis C virus (HCV) infection. ... based on information from the American Association for the ... sources. , Numerous new direct-acting oral medications to treat ...
Breaking Medicine News(10 mins):Health News:Herald Square Dental Celebrates Oral Cancer Awareness Month 2Health News:Bird B Gone Now Carries Complete Bird Netting Hardware 2Health News:Bird B Gone Now Carries Complete Bird Netting Hardware 3Health News:Prepare for potholes with 7 tips from Amica Insurance 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 2Health News:NLN Commission for Nursing Education Accreditation (NLN CNEA) Announces Inaugural Commissioners 3Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2
... Medical ... powerful partners for creating high quality medical transcriptions. , ... Scottsdale, AZ, (PRWEB) June 25, 2009 -- ... store medical information, but a physician,s dictation technique still plays a critical role in ...
... and Federal Healthcare Policy and Regulatory Team , ... the largest law firms in Florida and one of ... the expansion of its Healthcare practice with significant additions ... professionals have joined the practice in the firm,s Washington, ...
... German . , If you have hay ... to the nearest chemist. The drugs, on the other hand, ... animal experiments have been an essential step, yet they continue ... at offering an alternative to animal experiments," says Professor Heike ...
... ATS Medical, Inc. (Nasdaq: ATSI ), manufacturer ... announced participation in the upcoming joint meeting of the Society ... which is being held in Berlin on June 27-30, 2009. ... surgeons from around the world and provides an excellent venue ...
... UPMC Health Plan One of 17 Platinum-Level Award winners ... Health Plan have been honored by the National Business Group ... for innovative programs that promote a healthy workplace and for ... about their own health and well-being. , , UPMC ...
... Putting Patients First , , PRINCETON, N.J., June 25 ... for sponsoring legislation that will improve access to behavioral health ... , , Surveys have shown that N.J. patients have ... transfer to an appropriate behavioral health program. (see below.) ...
Cached Medicine News:Health News:Medical Transcription Services Company MxSecure, Inc. Announces Top Ten Dictation Tips for Physicians 2Health News:Medical Transcription Services Company MxSecure, Inc. Announces Top Ten Dictation Tips for Physicians 3Health News:Akerman Senterfitt Announces Expansion of Healthcare Practice 2Health News:Akerman Senterfitt Announces Expansion of Healthcare Practice 3Health News:Artificial liver for drug tests 2Health News:ATS Medical Announces Participation in the Joint Meeting of the Society for Heart Valve Disease and Heart Valve Society of America 2Health News:ATS Medical Announces Participation in the Joint Meeting of the Society for Heart Valve Disease and Heart Valve Society of America 3Health News:ATS Medical Announces Participation in the Joint Meeting of the Society for Heart Valve Disease and Heart Valve Society of America 4Health News:UPMC and UPMC Health Plan Recognized by National Business Group on Health As a Leading Employer Promoting Healthy Lifestyles for Its Employees 2Health News:UPMC and UPMC Health Plan Recognized by National Business Group on Health As a Leading Employer Promoting Healthy Lifestyles for Its Employees 3Health News:Bills Address Long Waits for Behavioral Health Patients 2Health News:Bills Address Long Waits for Behavioral Health Patients 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: